N-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclohexyl]prop-2-enamide;1-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]piperidin-1-yl]prop-2-en-1-one;1-[3-[[8-ethyl-2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]piperidin-1-yl]prop-2-en-1-one;N-[3-[[2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]-9-propan-2-ylpurin-6-yl]amino]cyclohexyl]prop-2-enamide
C93H140N26O8 — CID 160665276
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclohexyl]prop-2-enamide;1-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]piperidin-1-yl]prop-2-en-1-one;1-[3-[[8-ethyl-2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]piperidin-1-yl]prop-2-en-1-one;N-[3-[[2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]-9-propan-2-ylpurin-6-yl]amino]cyclohexyl]prop-2-enamide
N-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclohexyl]prop-2-enamide;1-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]piperidin-1-yl]prop-2-en-1-one;1-[3-[[8-ethyl-2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]piperidin-1-yl]prop-2-en-1-one;N-[3-[[2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]-9-propan-2-ylpurin-6-yl]amino]cyclohexyl]prop-2-enamide (PubChem CID 160665276) has the molecular formula C93H140N26O8 and a molecular weight of 1750.32 g/mol. Its IUPAC name is N-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclohexyl]prop-2-enamide;1-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]piperidin-1-yl]prop-2-en-1-one;1-[3-[[8-ethyl-2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]piperidin-1-yl]prop-2-en-1-one;N-[3-[[2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]-9-propan-2-ylpurin-6-yl]amino]cyclohexyl]prop-2-enamide.
Molecular Properties
| Compound Name | N-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclohexyl]prop-2-enamide;1-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]piperidin-1-yl]prop-2-en-1-one;1-[3-[[8-ethyl-2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]piperidin-1-yl]prop-2-en-1-one;N-[3-[[2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]-9-propan-2-ylpurin-6-yl]amino]cyclohexyl]prop-2-enamide |
|---|---|
| PubChem CID | 160665276 |
| Molecular Formula | C93H140N26O8 |
| Molecular Weight | 1750.32 g/mol |
| Exact Mass | 1749.13 |
| IUPAC Name | N-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclohexyl]prop-2-enamide;1-[3-[[3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]piperidin-1-yl]prop-2-en-1-one;1-[3-[[8-ethyl-2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a][1,3,5]triazin-4-yl]amino]piperidin-1-yl]prop-2-en-1-one;N-[3-[[2-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]-9-propan-2-ylpurin-6-yl]amino]cyclohexyl]prop-2-enamide |
| SMILES | C=CC(=O)N1CCCC(Nc2cc(N3CCCC[C@H]3CCO)nc3c(CC)cnn23)C1.C=CC(=O)N1CCCC(Nc2nc(N3CCCC[C@H]3CCO)nc3c(CC)cnn23)C1.C=CC(=O)NC1CCCC(Nc2cc(N3CCCC[C@H]3CCO)nc3c(CC)cnn23)C1.C=CC(=O)NC1CCCC(Nc2nc(N3CCCC[C@H]3CCO)nc3c2ncn3C(C)C)C1 |
| InChI | InChI=1S/C24H37N7O2.C24H36N6O2.C23H34N6O2.C22H33N7O2/c1-4-20(33)26-17-8-7-9-18(14-17)27-22-21-23(31(15-25-21)16(2)3)29-24(28-22)30-12-6-5-10-19(30)11-13-32;1-3-17-16-25-30-22(26-18-8-7-9-19(14-18)27-23(32)4-2)15-21(28-24(17)30)29-12-6-5-10-20(29)11-13-31;1-3-17-15-24-29-21(25-18-8-7-11-27(16-18)22(31)4-2)14-20(26-23(17)29)28-12-6-5-9-19(28)10-13-30;1-3-16-14-23-29-20(16)25-21(28-12-6-5-9-18(28)10-13-30)26-22(29)24-17-8-7-11-27(15-17)19(31)4-2/h4,15-19,32H,1,5-14H2,2-3H3,(H,26,33)(H,27,28,29);4,15-16,18-20,26,31H,2-3,5-14H2,1H3,(H,27,32);4,14-15,18-19,25,30H,2-3,5-13,16H2,1H3;4,14,17-18,30H,2-3,5-13,15H2,1H3,(H,24,25,26)/t17?,18?,19-;18?,19?,20-;18?,19-;17?,18-/m0000/s1 |
| InChIKey | RMFBPCZZEDPFIJ-UFMFYJTPSA-N |
| XLogP | 10.87 |
| TPSA | 387.88 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 127 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1750.32 |
| LogP ≤ 5 | 10.87 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 30 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160665276 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.